Analysis using the PIMA Indians dataset reveals that AMNN significantly improves diabetes prediction accuracy, suggesting reliable clinical applications.
Background: Early diabetes detection remains challenging, requiring robust machine learning approaches that balance accuracy with clinical interpretability for effective diagnostic support. Methods: We are proposing a novel Additive and Multiplicative Neurons Network (AMNN) that combines both additive and multiplicative computational pathways to capture complex nonlinear relationships in diabetes prediction. Using the PIMA Indians Diabetes dataset (n=768), we compared AMNN against nine established algorithms including XGBoost, KAN, and traditional neural networks. Data preprocessing included SMOTE oversampling for class imbalance, and model interpretability was enhanced through SHAP and LIME explainable AI techniques. Results: The AMNN model outperformed all baseline approaches, achieving 75.76% accuracy, a 76.18% F1-score, and an AUC-ROC of 0.8206. Across both traditional feature selection techniques and explainable AI analyses, glucose levels, BMI, age, and pregnancy count consistently emerged as the most influential predictors. Conclusions: The AMNN framework demonstrates strong potential for diabetes prediction by balancing accuracy with clinical interpretability. The key predictors it highlights align closely with established medical knowledge, reinforcing confidence in its outputs and suitability for use in clinical decision-making workflows. This hybrid neural network approach represents a promising step toward transparent, AI-assisted diagnostic tools that can support healthcare professionals in practice.
No takes yet. Share an insight, caveat, or question.
Demirel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: